StockData

RxSight, Inc. (RXST) income statement

RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3076% below fair value
$5.01+0.18 (+3.73%)

Close on Nov 18, 2026Market cap $208.38MP/E –Yield –

RxSight, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
77.5%
Operating margin
-43.2%
Net margin
-36.8%
Return on equity, FY2025
-14.0%

Financial strength

Current ratio
4.07
Debt to equity
–
Debt to assets
–
Cash to current liabilities
16.6%

Valuation

P/E ratio
–
Price to sales
1.63
Price to book
0.79
Dividend yield
–

See a number that looks wrong?